ACCME is pushing a plan to simply shut out physician instruction of drug company sponsored CME. It is a complex plan with room for loopholes but reflects an extraordinary push to get more accurate information about potential problems associated with inappropriate off label uses of pharmaceuticals. Norm Fost is quoted.
Labels: Conflict of Interest, limits, off-label use, pharmaceutical industry